Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Canagliflozin (November 2013)
    René Rodríguez-Gutiérrez, MD and Gloria Gonzalez-Saldivar, MD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 87-88; DOI: https://doi.org/10.3949/ccjm.81c.02003

    Readers comment on the measurement of serum calcium in a patient with tetany (June 2013) and on the metabolic side effects of canagliflozin (November 2013).

  • You have access
    Wide QRS complex rhythm with pulseless electrical activity
    Laszlo Littmann, MD, PhD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 81-82; DOI: https://doi.org/10.3949/ccjm.81a.13079

    Although this presentation is grave, several of its possible causes can be treated, allowing the patient to recover.

  • Anticoagulation and antiplatelet therapy in acute coronary syndromes
    You have access
    Anticoagulation and antiplatelet therapy in acute coronary syndromes
    Dhssraj Singh, MD, Kamal Gupta, MD and James L. Vacek, MD, MSc
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 103-114; DOI: https://doi.org/10.3949/ccjm.81a.13016

    Antiplatelet and anticoagulant drugs prevent ischemic events but can cause bleeding. Here is how to optimize the benefit.

  • You have access
    Slow-growing angiomatous lesions on the limbs
    José Ramón Estela Cubells, MD, Amparo Pérez Ferriols, MD and Víctor Alegre De Miquel, MD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 79-80; DOI: https://doi.org/10.3949/ccjm.81a.13058

    Erythematous plaques after age 70 should raise the suspicion of classic Kaposi sarcoma.

  • You have access
    Clinical update in sexually transmitted diseases –2014
    Robyn Neblett Fanfair, MD, MPH and Kimberly A. Workowski, MD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 91-101; DOI: https://doi.org/10.3949/ccjm.81a.13090

    With recent changes to the health care landscape, expect to encounter more patients with STDs.

  • You have access
    Should patients with gout avoid
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 83-86; DOI: https://doi.org/10.3949/ccjm.81a.13131

    No study has directly addressed this issue. In most cases, continue the thiazide and adjust the hypouricemic therapy if necessary.

  • You have access
    The impact of anti-TNF therapy on the nonspecialist
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 71-72; DOI: https://doi.org/10.3949/ccjm.81b.02014

    These drugs are being used in a growing number of diseases. We all need to increase our familiarity with their unique risks.

  • You have access
    In Reply: Canagliflozin (November 2013)
    Mary Vouyiouklis, MD
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 90; DOI: https://doi.org/10.3949/ccjm.81c.02005
  • You have access
    Reviewers 2013
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 102;
  • You have access
    Managing risks of TNF inhibitors: An update for the internist
    Jennifer Hadam, MD, Elie Aoun, MD, MS, Kofi Clarke, MD and Mary Chester Wasko, MD, MSc
    Cleveland Clinic Journal of Medicine February 2014, 81 (2) 115-127; DOI: https://doi.org/10.3949/ccjm.81a.12121

    Tumor necrosis factor inhibitors pose infrequent but serious risks, including infection and malignancy.

Pages

  • Previous
  • Next
  • 1
  • …
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • …
  • 798

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire